Evavold BD - Search Results

1

A unique unresponsive CD4+ T cell phenotype post TCR antagonism.

Edwards LJ, Evavold BD. Edwards LJ, et al. Among authors: evavold bd. Cell Immunol. 2010;261(1):64-8. doi: 10.1016/j.cellimm.2009.11.002. Epub 2009 Dec 23. Cell Immunol. 2010. PMID: 20031121 Free PMC article.

2

Persistence of peptide-induced CD4+ T cell anergy in vitro.

Ryan KR, Evavold BD. Ryan KR, et al. Among authors: evavold bd. J Exp Med. 1998 Jan 5;187(1):89-96. doi: 10.1084/jem.187.1.89. J Exp Med. 1998. PMID: 9419214 Free PMC article.

3

Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities.

Robertson JM, Evavold BD. Robertson JM, et al. Among authors: evavold bd. J Immunol. 1999 Aug 15;163(4):1750-4. J Immunol. 1999. PMID: 10438905

4

DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope.

Robertson JM, Jensen PE, Evavold BD. Robertson JM, et al. Among authors: evavold bd. J Immunol. 2000 May 1;164(9):4706-12. doi: 10.4049/jimmunol.164.9.4706. J Immunol. 2000. PMID: 10779776

5

Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.

McNeil LK, Evavold BD. McNeil LK, et al. Among authors: evavold bd. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4520-5. doi: 10.1073/pnas.072673899. Epub 2002 Mar 19. Proc Natl Acad Sci U S A. 2002. PMID: 11904393 Free PMC article.

6

TCR reserve: a novel principle of CD4 T cell activation by weak ligands.

McNeil LK, Evavold BD. McNeil LK, et al. Among authors: evavold bd. J Immunol. 2003 Feb 1;170(3):1224-30. doi: 10.4049/jimmunol.170.3.1224. J Immunol. 2003. PMID: 12538680

7

Cutting edge: dependence of TCR antagonism on Src homology 2 domain-containing protein tyrosine phosphatase activity.

Kilgore NE, Carter JD, Lorenz U, Evavold BD. Kilgore NE, et al. Among authors: evavold bd. J Immunol. 2003 May 15;170(10):4891-5. doi: 10.4049/jimmunol.170.10.4891. J Immunol. 2003. PMID: 12734331

8

Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55.

Ford ML, Evavold BD. Ford ML, et al. Among authors: evavold bd. J Immunol. 2003 Aug 1;171(3):1247-54. doi: 10.4049/jimmunol.171.3.1247. J Immunol. 2003. PMID: 12874212

9

CD43 modulates severity and onset of experimental autoimmune encephalomyelitis.

Ford ML, Onami TM, Sperling AI, Ahmed R, Evavold BD. Ford ML, et al. Among authors: evavold bd. J Immunol. 2003 Dec 15;171(12):6527-33. doi: 10.4049/jimmunol.171.12.6527. J Immunol. 2003. PMID: 14662853

10

An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.

Ford ML, Evavold BD. Ford ML, et al. Among authors: evavold bd. Eur J Immunol. 2004 Feb;34(2):388-97. doi: 10.1002/eji.200324502. Eur J Immunol. 2004. PMID: 14768043 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters